ProShare Advisors LLC Has $203.55 Million Position in Cardinal Health, Inc. (NYSE:CAH)

ProShare Advisors LLC cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 8.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,721,031 shares of the company's stock after selling 152,711 shares during the period. ProShare Advisors LLC owned 0.71% of Cardinal Health worth $203,546,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CAH. Rothschild Investment LLC lifted its position in shares of Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after buying an additional 79 shares during the last quarter. Private Trust Co. NA raised its stake in Cardinal Health by 11.0% in the 4th quarter. Private Trust Co. NA now owns 930 shares of the company's stock valued at $110,000 after acquiring an additional 92 shares during the period. Checchi Capital Advisers LLC lifted its holdings in Cardinal Health by 2.7% during the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after purchasing an additional 93 shares during the last quarter. TIAA Trust National Association lifted its holdings in Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after purchasing an additional 94 shares during the last quarter. Finally, MWA Asset Management boosted its position in Cardinal Health by 2.9% during the fourth quarter. MWA Asset Management now owns 3,324 shares of the company's stock worth $393,000 after purchasing an additional 95 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.7%

NYSE CAH traded up $1.15 during midday trading on Tuesday, hitting $155.01. The company had a trading volume of 815,200 shares, compared to its average volume of 2,550,539. The firm has a 50-day moving average price of $137.63 and a 200-day moving average price of $128.19. The company has a market capitalization of $37.00 billion, a PE ratio of 28.94, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $156.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Cardinal Health's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.08 earnings per share. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's payout ratio is currently 31.83%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CAH. StockNews.com raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Robert W. Baird upped their price target on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Bank of America raised their price objective on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. UBS Group boosted their price objective on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Finally, Morgan Stanley upped their target price on Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and an average price target of $146.43.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.